市場調査レポート
商品コード
1496710
輸液ポンプ市場:製品別、モード別、操作別、用途別、エンドユーザー別 - 世界予測、2024~2030年Infusion Pumps Market by Product (Ambulatory Infusion Pump, Enteral Infusion Pump, Implantable Infusion Pump), Mode (Portable Infusion Pump, Stationary Infusion Pump), Operation, Application, End User - Global Forecast 2024-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
輸液ポンプ市場:製品別、モード別、操作別、用途別、エンドユーザー別 - 世界予測、2024~2030年 |
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 191 Pages
納期: 即日から翌営業日
|
世界の輸液ポンプの市場規模は、2023年に180億3,000万米ドルとなり、2024年に192億5,000万米ドルに達し、CAGR7.21%で2030年までに293億6,000万米ドルに達すると予測されます。
輸液ポンプは、薬剤や栄養剤、水分補給用の液体などの流体を、制御された正確な方法で患者の体内に送り込むために使用される医療機器です。これらのポンプは、患者の治療計画に応じて、正確な投与と継続的な投与を保証するために、特定の期間にわたって制御された量の液体を投与するように設計されています。輸液ポンプは、化学療法薬、抗生物質、鎮痛剤、インスリン、または調節された投与が必要なその他の治療薬を投与するために、病院、在宅介護環境、および診療所で一般的に使用されています。慢性疾患の有病率の増加や高齢者人口の増加により、輸液ポンプは便利な薬剤送達のための重要な必要性を確立しています。しかし、輸液ポンプに関連した投薬ミスの発生、製品認可のための厳しい規制要件、輸液ポンプ装置の高コストが、輸液ポンプの開発を妨げています。市場関係者は、輸液ポンプの機能を向上させながら、これらの制限に対処するための費用対効果の高い製品を提供するため、一貫した研究開発に取り組んでいます。安全機能やワイヤレス接続を強化したスマート輸液ポンプシステムの市場開拓は、市場拡大のさらなるチャンスをもたらします。輸液ポンプと電子カルテ(EMR)の統合、ユーザーフレンドリーなインターフェースの開発、スマートアラームなどのイノベーションが輸液ポンプのビジネスチャンスを形成します。
主な市場の統計 | |
---|---|
基準年[2023年] | 180億3,000万米ドル |
予測年[2024年] | 192億5,000万米ドル |
予測年[2030年] | 293億6,000万米ドル |
CAGR(%) | 7.21% |
地域別洞察
南北アメリカ地域は、強固なヘルスケアインフラ、政府による高額なヘルスケア支出、複数の主要企業によって特徴付けられ、輸液ポンプの成長と需要を促進しています。また、同地域は絶え間ない製品革新に取り組んでおり、FDA(食品医薬品局)などの規制機関は輸液ポンプの医療機器認可を頻繁に合理化しています。さらに、技術革新が輸液デバイスのスマート技術やワイヤレスモニタリングの統合に拍車をかけています。EU諸国は、輸液デバイスの品質と安全性を保証する高いヘルスケア基準と厳しい規制の恩恵を受けています。加盟国間の協力やヘルスケア技術への多額の投資が、EUにおける輸液ポンプの研究開発を促進しています。EUでは、個別化医療や在宅輸液療法の需要も高まっています。アジア太平洋は、医療費の増加と先進的な治療法に対する意識の高まりにより、市場が急成長しています。中国、日本、インドなどの国々がこの地域の拡大に貢献しています。中国では、ヘルスケアの近代化と農村部へのアクセス拡大に対する政府の取り組みが市場成長を後押ししています。
FPNVポジショニングマトリックス
FPNVポジショニングマトリックスは、輸液ポンプ市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。
市場シェア分析
市場シェア分析は、輸液ポンプ市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。
戦略分析と提言
戦略分析は、世界市場で確固たる足場を築こうとする組織にとって不可欠です。企業は、輸液ポンプ市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。
[191 Pages Report] The Infusion Pumps Market size was estimated at USD 18.03 billion in 2023 and expected to reach USD 19.25 billion in 2024, at a CAGR 7.21% to reach USD 29.36 billion by 2030.
An infusion pump is a medical device used to deliver fluids, such as medications, nutrients, or liquids for hydration, into a patient's body in a controlled and precise manner. These pumps are designed to administer liquids in controlled amounts over specific periods, ensuring accurate dosing and continuous delivery as required by the patient's treatment plan. Infusion pumps are commonly used in hospitals, homecare settings, and clinics for delivering chemotherapy drugs, antibiotics, pain relievers, insulin, or other therapies requiring regulated administration. The increasing prevalence of chronic diseases and rising elderly population has established a significant need for infusion pumps for convenient delivery of medications. However, the occurrence of medication errors associated with infusion pumps, stringent regulatory requirements for product approval, and the high cost of infusion pump devices impede the development of infusion pumps. Market players are working on consistent R&D to improve the capabilities of infusion pumps while offering cost-effective products to address these limitations. Developing smart infusion pump systems with enhanced safety features and wireless connectivity presents additional opportunities for market expansion. Innovations such as integrating infusion pumps with electronic medical records (EMR), developing user-friendly interfaces, and smart alarms form opportunities for infusion pumps.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.03 billion |
Estimated Year [2024] | USD 19.25 billion |
Forecast Year [2030] | USD 29.36 billion |
CAGR (%) | 7.21% |
Regional Insights
The Americas region is characterized by a robust healthcare infrastructure, high government healthcare spending, and several key players, thereby driving the region's growth and demand for infusion pumps. The region is also involved in constant product innovations, and regulatory bodies such as the Food and Drug Administration (FDA) frequently streamline medical device approvals for infusion pumps. Furthermore, technological innovations have fuelled the integration of smart technologies and wireless monitoring in infusion devices. EU countries benefit from high healthcare standards and stringent regulations that ensure the quality and safety of infusion devices. Collaborations amongst member states and substantial investment in healthcare technology drive research and development for infusion pumps in the EU. The EU also experiences a rising demand for personalized medicine and home infusion therapy. The Asia-Pacific region is experiencing rapid market growth due to rising healthcare expenditures and increasing awareness of advanced therapeutic options. Countries such as China, Japan, and India contribute to the region's expansion. In China, government initiatives to modernize healthcare and expand rural access have bolstered the market growth.
Market Insights
The market dynamics represent an ever-changing landscape of the Infusion Pumps Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infusion Pumps Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infusion Pumps Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fresenius Kabi, Mayo Clinic ink Deal On Ivenix Infusion System
Fresenius Kabi has joined forces with the esteemed Mayo Clinic to implement the innovative Ivenix Infusion System. This state-of-the-art technology promises to revolutionize the infusion pump market by offering advanced safety features and an intuitive user interface to minimize medication errors and enhance patient care. The partnership highlights a collaborative commitment to clinical excellence, with the Ivenix system as a critical component in facilitating effective, real-time infusion data integration into electronic medical records (EMRs), thus enabling healthcare professionals to deliver high-quality, efficient patient care. [Published On: 2023-12-15]
Tandem Diabetes Care Launches First Automated Insulin Pump Integrated With Dexcom G7 CGM
Tandem Diabetes Care has announced the launch of an advanced automated insulin delivery system. This new offering, combined with the Dexcom G7 continuous glucose monitoring (CGM) system, embodies a landmark in precision medicine, providing diabetes patients with a more autonomous and personalized treatment solution. Leveraging cutting-edge algorithms, the system automates insulin delivery with heightened accuracy, enhancing the user's control over their glucose levels without constant manual adjustments. The union of Tandem's automated insulin pump with Dexcom's CGM system is emblematic of the strides being made in the field of diabetes care, where innovation is directly translating to improved quality of life for individuals living with this chronic illness. [Published On: 2023-12-06]
Monidor Expands Remote IV Therapy Monitoring in Collaboration with B. Braun
Monidor has enhanced its market presence by partnering with B. Braun SE to advance remote IV therapy monitoring. Leveraging Monidor's expertise and B. Braun's extensive distribution network, this partnership aims to optimize infusion therapies and improve patient care. Integrating Monidor's Monidrop device and the MoniView software with B. Braun's infusion systems facilitates accurate administration and oversight of IV fluids remotely, thus ensuring precise dosing and reducing the likelihood of manual errors. [Published On: 2023-08-29]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infusion Pumps Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Infusion Pumps Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Avanos Medical, Inc., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Bio-x, Boston Scientific Corporation, Canadian Hospital Specialties Limited, Chemyx Inc., Epic Medical Pty Ltd., Fresenius Se & Co. KGaA, FUJIFILM Corporation, GE HealthCare Technologies Inc., ICU Medical, Inc., Insulet Corporation, Intera Oncology, Inc., Intuvie Holdings LLC, Ivenix, Inc., JMS Co., Ltd., Longer Precision Pump Co. Ltd. by Halma PLC, Medline Industries, LP, Medtronic PLC, Merck KGaA, Micrel Medical Devices SA, Moog Inc., Narang Medical Limited, New Era Pump Systems Inc., Nipro Corporation, Shenzhen MedRena Biotech Co., Ltd., SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD., Siemens AG, SOOIL Developments Co., Ltd., Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., and Ypsomed AG.
Market Segmentation & Coverage